tiprankstipranks
NeuBase Therapeutics Inc (NBSE)
NASDAQ:NBSE

NeuBase Therapeutics (NBSE) Ownership - Who Owns NeuBase Therapeutics?

495 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 18, 2023
Symetryx Corp
>10% Owner
Sold$375620
Sep 11, 2023
Symetryx Corp
>10% Owner
Sold$336731
Sep 07, 2023
Symetryx Corp
>10% Owner
Bought$59244
Aug 04, 2023
Stephan Dietrich A
Founder And Ceo,director, >10% Owner
Bought$1865

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,644,947Insider43.85%712,262
1,563,619Insider41.68%677,047
762,102Insider20.31%329,990
136,350Institution3.63%59,040
45,600Insider1.22%19,745
33,800Insider0.90%14,635
18,981Institution0.51%8,219
18,981Institution0.51%8,219
15,655Institution0.42%6,779
14,985Institution0.40%6,489

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
18,981Institution0.51%8,219
15,655Institution0.42%6,779
14,985Institution0.40%6,489
1,485Institution0.04%643

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
18,981Institution0.51%8,390

FAQ

Who Owns NeuBase Therapeutics Inc (NBSE)?
Currently, no data Available
What percentage of NeuBase Therapeutics Inc (NBSE) stock is held by institutional investors?
Currently, no data Available
What percentage of NeuBase Therapeutics Inc (NBSE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of NeuBase Therapeutics Inc (NBSE)?
Orin Hirschman owns the most shares of NeuBase Therapeutics Inc (NBSE).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis